CEFOCAR-CV 325: Powerful Duo for Resistant Bacterial Infections

CEFOCAR-CV 325 tablets from MK Healthcare represent an advanced combination therapy specifically designed to combat complex and increasingly antibiotic-resistant bacterial infections. This formulation pairs Cefpodoxime Proxetil (200mg), a potent third-generation cephalosporin, with Clavulanic Acid (125mg). This synergistic combination provides a robust defense against pathogens that produce beta-lactamase enzymes, which typically inactivate many other antibiotics. CEFOCAR-CV 325 is thus an essential tool when standard antibiotic therapy may fail.

Mechanism: Overcoming Bacterial Resistance

The primary function of Clavulanic Acid in CEFOCAR-CV 325 is to act as a beta-lactamase inhibitor. Many resistant bacteria produce these enzymes to destroy the Cefpodoxime molecule before it can work. By binding to and deactivating these enzymes, Clavulanic Acid effectively 'protects' the Cefpodoxime, allowing the full bactericidal power of the 200mg dose to penetrate the bacteria and inhibit cell wall synthesis. This unique dual-action mechanism significantly expands the spectrum of activity and ensures high clinical success rates.

Key Applications in Severe and Resistant Infections

CEFOCAR-CV 325 is widely indicated for the treatment of severe bacterial infections that require enhanced potency. This includes complicated Respiratory Tract Infections (RTIs) such as community-acquired pneumonia and severe sinusitis, as well as complex Urinary Tract Infections (UTIs), Skin and Soft Tissue Infections, and otitis media. The combination is particularly valuable when the causative organism is suspected or known to be resistant, making it a reliable and crucial choice for targeted infection management.

MK Healthcare: Trustworthy Partner for Advanced Antibiotics

MK Healthcare, an ISO-GMP certified company, ensures that CEFOCAR-CV 325 (Cefpodoxime 200mg + Clavulanic Acid 125mg) is manufactured under rigorous quality control standards. This commitment guarantees a high-quality, therapeutically superior product essential for treating challenging infections. For healthcare providers and distributors seeking a high-efficacy, broad-spectrum antibiotic combination, CEFOCAR-CV 325 is a premium offering that reinforces our dedication to combating antimicrobial resistance and improving patient outcomes.